Back to Agenda
Calling All Angels to the Valley of Death
Session Chair(s)
David Vulcano, MBA, RAC
Honorary President (SCRS); VP, Clinical Research Compliance and Integrity (HCA
HCA Healthcare | Society Clinical Research Sites, United States
The Valley of Death refers to the obstacles that are keeping innovative medical research discoveries from becoming new therapies or even making it to clinical trials. Funding is necessary to bridge the gap. This session will provide insight into strategies used by translational research scientists and funding agencies to expedite the transformation of basic research into break through clinical applications.
Learning Objective : Describe strategies used to expedite the transformation of basic research into breakthrough clinical applications.
Speaker(s)
What Angel Investors Think About Medical Product Investing
David Vulcano, MBA, RAC
HCA Healthcare | Society Clinical Research Sites, United States
Honorary President (SCRS); VP, Clinical Research Compliance and Integrity (HCA
NCATS Small Business Opportunities
Christine Colvis, PhD
National Center for Advancing Translational Sciences (NCATS), United States
Director, Drug Development Partnership Programs
Panelist
Ginger A Spitzer, MA
Foundation of Sarcoidosis Research, United States
Executive Director
Have an account?